摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-[[3-(4-Methoxyphenyl)-1-phenylpyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-diazinane-4,6-dione

中文名称
——
中文别名
——
英文名称
5-[[3-(4-Methoxyphenyl)-1-phenylpyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-diazinane-4,6-dione
英文别名
——
5-[[3-(4-Methoxyphenyl)-1-phenylpyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-diazinane-4,6-dione化学式
CAS
——
化学式
C21H16N4O3S
mdl
——
分子量
404.4
InChiKey
QQKNAMQONXLIKM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    29
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.05
  • 拓扑面积:
    117
  • 氢给体数:
    2
  • 氢受体数:
    5

文献信息

  • Prostaglandin E synthase inhibitors and methods for utilizing the same
    申请人:University of Kentucky Research Foundation
    公开号:US11325901B2
    公开(公告)日:2022-05-10
    Compounds and compositions are provided that can inhibit microsomal prostaglandin E synthase-1 (mPGES-1). The compounds and compositions can reduce inflammation in a subject, such as inflammation caused by an inflammation disorder or symptoms thereof. Pharmaceutical compositions comprising the compound are also provided. Furthermore, methods are provided for reducing inflammation and/or inhibiting mPGES-1. The methods can comprise administering an effective amount of the composition to a subject.
    本研究提供了可抑制微粒体前列腺素 E 合酶-1(mPGES-1)的化合物和组合物。这些化合物和组合物可以减轻受试者的炎症,如炎症性疾病引起的炎症或其症状。还提供了包含该化合物的药物组合物。此外,还提供了减轻炎症和/或抑制 mPGES-1 的方法。这些方法可包括向受试者施用有效量的组合物。
  • Prostaglandin E Synthase Inhibitors and Methods for Utilizing the Same
    申请人:University of Kentucky Research Foundation
    公开号:US20200231583A1
    公开(公告)日:2020-07-23
    Compounds and compositions are provided that can inhibit microsomal prostaglandin E synthase-1 (mPGES-1). The compounds and compositions can reduce inflammation in a subject, such as inflammation caused by an inflammation disorder or symptoms thereof. Pharmaceutical compositions comprising the compound are also provided. Furthermore, methods are provided for reducing inflammation and/or inhibiting mPGES-1. The methods can comprise administering an effective amount of the composition to a subject.
查看更多